Avelumab (anti-PD-L1)

HY-108730A

Avelumab (anti-PD-L1)

Avelumab (anti-PD-L1) is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity[1].

1422.74 €

E2209924

Anti-PD-L1 [Avelumab]

Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Ask for quotation

MBS4751611-01mL

Anti-PD-L1 [Avelumab] Humanized

758.75 €

MBS684298-7mLRTU

Anti-PD-L1

1096.62 €

34091

Anti-Canine PD-L1

840 €

34068

Anti-PD-L1 Antibody

499.5 €